Increasing life expectancy in cystic fibrosis: Advances and challenges.

Increasing life expectancy in cystic fibrosis: Advances and challenges.
复制标题

DOI:
10.1002/ppul.25733
复制
发表时间:
2022-03
影响因子:
3.1
通讯作者:
Konstan, Michael W.
Konstan, Michael W.
中科院分区:
医学3区
文献类型:
--
作者:
McBennett, Kimberly A.;Davis, Pamela B.;Konstan, Michael W.

文献摘要

参考文献

被引文献

相似文献

自1938年第一次描述囊性纤维化以来,患有这种疾病的人的生活质量和寿命都有了重大进展。在这篇文章中,我们描述了过去80年的里程碑,以及我们认为对这一人群来说仍然存在的正常障碍。
Since the first description of cystic fibrosis in 1938, there have been significant advances in both quality of life and longevity for people living with this disease. In this article we describe the milestones of the last 80 years and what we perceive to be the remaining barriers to normalcy for this population.
DOI: 10.1136/thoraxjnl-2015-207360
发表时间: 2016-01
期刊: Thorax
影响因子: 10
作者:
Floto RA;Olivier KN;Saiman L;Daley CL;Herrmann JL;Nick JA;Noone PG;Bilton D;Corris P;Gibson RL;Hempstead SE;Koetz K;Sabadosa KA;Sermet-Gaudelus I;Smyth AR;van Ingen J;Wallace RJ;Winthrop KL;Marshall BC;Haworth CS;US Cystic Fibrosis Foundation and European Cystic Fibrosis Society
通讯作者: US Cystic Fibrosis Foundation and European Cystic Fibrosis Society
DOI: 10.1016/j.jcf.2017.06.002
发表时间: 2018-01-01
影响因子: 5.2
作者:
Flume, Patrick A.;Wainwright, Claire E.;Wagener, Jeffrey S.
通讯作者: Wagener, Jeffrey S.
DOI: 10.1001/jama.239.18.1851
发表时间: 1978-01-01
影响因子: 120.7
作者:
DAVIS, PB;DISANTAGNESE, PA
通讯作者: DISANTAGNESE, PA
DOI: 10.1378/chest.14-2189
发表时间: 2016-02-01
期刊: CHEST
影响因子: 9.6
作者:
Buu, MyMy C.;Sanders, Lee M.;Wise, Paul H.
通讯作者: Wise, Paul H.
DOI: 10.3390/jcm10010023
发表时间: 2020-12-23
影响因子: 3.9
作者:
Dagenais RVE;Su VCH;Quon BS
通讯作者: Quon BS